blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3377635

EP3377635 - T7 ALPHA VIRAL VECTOR SYSTEM [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.09.2023
Database last updated on 19.10.2024
FormerRequest for examination was made
Status updated on  24.08.2018
FormerThe international publication has been made
Status updated on  26.05.2017
Most recent event   Tooltip29.09.2023Application deemed to be withdrawnpublished on 01.11.2023  [2023/44]
Applicant(s)For all designated states
Orbis Health Solutions LLC
111 Smith Hines Road, Suite E&F
Greenville, SC 29607 / US
[2018/39]
Inventor(s)01 / WAGNER, Thomas E.
104 Golden Wings Way
Greenville, South Carolina 29650 / US
 [2018/39]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2018/39]
Application number, filing date16867199.818.11.2016
[2018/39]
WO2016US62703
Priority number, dateUS201562256788P18.11.2015         Original published format: US 201562256788 P
[2018/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017087763
Date:26.05.2017
Language:EN
[2017/21]
Type: A1 Application with search report 
No.:EP3377635
Date:26.09.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 26.05.2017 takes the place of the publication of the European patent application.
[2018/39]
Search report(s)International search report - published on:US26.05.2017
(Supplementary) European search report - dispatched on:EP10.04.2019
ClassificationIPC:C12N15/86, C12N7/02, C12N5/074, C12N5/071
[2018/39]
CPC:
C12N15/86 (EP,US); A61K39/12 (EP,US); A61K39/145 (US);
A61P37/04 (EP,US); C07K14/005 (EP,US); C12N5/0696 (US);
A61K2039/53 (US); A61K2039/876 (US); C12N2501/20 (US);
C12N2760/16034 (EP,US); C12N2770/36134 (EP,US); C12N2770/36143 (EP,US);
C12N2770/36151 (EP,US); C12N2770/36152 (EP,US); C12N2795/10222 (EP,US);
C12N2830/00 (EP,US); C12N2840/203 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/39]
TitleGerman:T7-ALPHA-VIRUSVEKTORSYSTEM[2018/39]
English:T7 ALPHA VIRAL VECTOR SYSTEM[2018/39]
French:SYSTÈME DE VECTEUR VIRAL ALPHA T7[2018/39]
Entry into regional phase18.06.2018National basic fee paid 
18.06.2018Search fee paid 
18.06.2018Designation fee(s) paid 
18.06.2018Examination fee paid 
Examination procedure18.06.2018Examination requested  [2018/39]
18.06.2018Date on which the examining division has become responsible
11.11.2019Amendment by applicant (claims and/or description)
01.06.2023Application deemed to be withdrawn, date of legal effect  [2023/44]
22.06.2023Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2023/44]
Fees paidRenewal fee
14.11.2018Renewal fee patent year 03
14.11.2019Renewal fee patent year 04
27.11.2020Renewal fee patent year 05
17.05.2022Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.11.202106   M06   Fee paid on   17.05.2022
30.11.202207   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO2004085660  (ALPHAVAX INC [US], et al) [X] 1-7,11,12 * page 7, line 21 - page 13, line 7 * * page 24, line 24 - page 25, line 17; example -; claim - * [Y] 1-15;
 [XY]WO2012058072  (HARRISVACCINES INC [US], et al) [X] 5-7 * figure 8; example -; claim - * [Y] 1-15;
 [XY]WO2013177133  (UNIVERISITY OF CALIFORNIA [US]) [X] 5-7 * paragraph [0002] - paragraph [0008] * * paragraph [0041] * * paragraph [0052] - paragraph [0055]; figure 1; example -; claim -; sequences 29-32 * [Y] 1-15;
 [X]  - MORAN T P ET AL, "Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice", VACCINE, ELSEVIER, AMSTERDAM, NL, (20070808), vol. 25, no. 36, doi:10.1016/J.VACCINE.2007.06.058, ISSN 0264-410X, pages 6604 - 6612, XP022191550 [X] 13-15 * abstract, materials and methods; results; discussion; *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2007.06.058
 [X]  - DI MASSIMO N ET AL, "Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34 ? -Derived Dendritic Cell Vaccination: A Phase I Trial in Metastatic Melanoma", CLINICAL CANCER RESEARCH, (20040815), vol. 10, pages 5381 - 5390, XP055575673 [X] 13-15 * abstract; results; discussion; *
 [Y]  - SPUUL P ET AL, "Assembly of Alphavirus Replication Complexes from RNA and Protein Components in a Novel trans-Replication System in Mammalian Cells", JOURNAL OF VIROLOGY., US, (20110515), vol. 85, no. 10, doi:10.1128/JVI.00085-11, ISSN 0022-538X, pages 4739 - 4751, XP055273102 [Y] 1-15 * abstract; materials and methods; results; *

DOI:   http://dx.doi.org/10.1128/JVI.00085-11
 [A]  - GAO X ET AL, "CYTOPLASMIC EXPRESSION OF A REPORTER GENE BY CO-DELIVERY OF T7 RNA POLYMERASE AND T7 PROMOTER SEQUENCE WITH CATIONIC LIPOSOMES", NUCLEIC ACIDS RESEARCH, INFORMATION RETRIEVAL LTD, (19930625), vol. 21, no. 12, ISSN 0305-1048, pages 2867 - 2872, XP000572618 [A] 1-15 * abstract; results; discussion; *
 [Y]  - Ghaderi M ET AL, "Construction of an eGFP Expression Plasmid under Control of T7 Promoter and IRES Sequence for Assay of T7 RNA Polymerase Activity in Mammalian Cell Lines", Iranian journal of cancer prevention, vol. 7, no. 3, (20140101), pages 137 - 141, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171830/pdf/IJCP-07-137.pdf, XP055491850 [Y] 1-15 * abstract; introduction; discussion; *
International search[A]US6387888  (MINCHEFF MILCHO S [US], et al) [A] 1-31* ; entire document *;
 [Y]US2005277605  (WU TZYY-CHOOU [US], et al) [Y] 25-31 * ; abstract; paragraphs [0002], [0183], [0186] *;
 [XY]US2007166820  (SMITH JONATHAN F [US], et al) [X] 1-16, 21-24 * ; abstract; paragraphs [0009], [0011], [0027], 0028], [0031], [0033], [0037], [0039], [0045]-[0047], [0051], [0055], [0065], [0074], [0076], [0085], [0090], [0091] * [Y] 25-31;
 [Y]US2012207744  (MENDLEIN JOHN D [US], et al) [Y] 19, 20 * ; paragraphs [0262], [0397] *;
 [Y]US2013078205  (DAYAN NAVA [US], et al) [Y] 27, 29-31 * ; paragraphs [0035], [0048] *;
 [XY]US2015159143  (DOWDY STEVEN F [US], et al) [X] 17, 18 * ; abstract; paragraphs [0002], [0005], [0006]-[0008], [0032], [0043], [0046], [0072], [0076], [0095], [0099], [0153], [0159] * [Y] 1-9, 20
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.